Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 322 | $203,380,051 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
04 May 2022 17:21 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 02 May 2022 | Sale | 306 | 263.98 | 80,778 | D |
04 May 2022 17:09 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 02 May 2022 | Sale | 6 | 264.37 | 1,586 | D |
04 May 2022 17:09 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 02 May 2022 | Sale | 91 | 261.91 | 23,834 | D |
04 May 2022 17:09 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 02 May 2022 | Sale | 80 | 260.82 | 20,866 | D |
04 May 2022 17:09 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 02 May 2022 | Sale | 120 | 259.75 | 31,170 | D |
04 May 2022 17:09 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 02 May 2022 | Sale | 120 | 258.9 | 31,068 | D |
04 May 2022 17:09 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 02 May 2022 | Sale | 280 | 257.51 | 72,103 | D |
04 May 2022 17:09 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 02 May 2022 | Sale | 40 | 255.4 | 10,216 | D |
04 May 2022 17:10 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 02 May 2022 | Sale | 4 | 264.37 | 1,057 | D |
04 May 2022 17:10 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 02 May 2022 | Sale | 65 | 261.79 | 17,016 | D |
04 May 2022 17:10 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 02 May 2022 | Sale | 23 | 260.44 | 5,990 | D |
04 May 2022 17:10 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 02 May 2022 | Sale | 75 | 259.58 | 19,468 | D |
04 May 2022 17:10 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 02 May 2022 | Sale | 43 | 258.46 | 11,114 | D |
04 May 2022 17:10 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 02 May 2022 | Sale | 90 | 257.49 | 23,174 | D |
04 May 2022 17:10 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 02 May 2022 | Sale | 20 | 255.47 | 5,109 | D |
04 May 2022 17:07 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 02 May 2022 | Sale | 3 | 264.37 | 793 | D |
04 May 2022 17:07 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 02 May 2022 | Sale | 32 | 262.06 | 8,386 | D |
04 May 2022 17:07 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 02 May 2022 | Sale | 48 | 261.15 | 12,535 | D |
04 May 2022 17:07 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 02 May 2022 | Sale | 80 | 259.45 | 20,756 | D |
04 May 2022 17:07 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 02 May 2022 | Sale | 60 | 258.21 | 15,493 | D |
04 May 2022 17:07 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 02 May 2022 | Sale | 100 | 257.18 | 25,718 | D |
04 May 2022 17:07 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 02 May 2022 | Sale | 20 | 254.87 | 5,097 | D |
06 May 2022 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 04 May 2022 | Sale | 36 | 275.09 | 9,903 | D |
18 May 2022 16:21 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 16 May 2022 | Sale | 40 | 254.19 | 10,168 | D |
18 May 2022 16:21 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 16 May 2022 | Sale | 10 | 252.66 | 2,527 | D |
18 May 2022 16:21 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 16 May 2022 | Sale | 10 | 251.43 | 2,514 | D |
18 May 2022 16:21 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 16 May 2022 | Sale | 32 | 250.78 | 8,025 | D |
18 May 2022 16:21 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 16 May 2022 | Sale | 20 | 249.35 | 4,987 | D |
18 May 2022 16:21 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 16 May 2022 | Sale | 10 | 247.95 | 2,480 | D |
18 May 2022 16:21 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 16 May 2022 | Sale | 11 | 246.21 | 2,708 | D |
18 May 2022 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 16 May 2022 | Sale | 8 | 254.44 | 2,036 | D |
18 May 2022 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 16 May 2022 | Sale | 15 | 253.99 | 3,810 | D |
18 May 2022 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 16 May 2022 | Sale | 7 | 252.43 | 1,767 | D |
18 May 2022 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 16 May 2022 | Sale | 8 | 251.37 | 2,011 | D |
18 May 2022 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 16 May 2022 | Sale | 7 | 250.56 | 1,754 | D |
18 May 2022 16:18 | VRTX | VERTEX PHARMACEUTICALS INC | LIU JOY | SVP, General Counsel | 16 May 2022 | Sale | 35 | 254.36 | 8,903 | D |
18 May 2022 16:18 | VRTX | VERTEX PHARMACEUTICALS INC | LIU JOY | SVP, General Counsel | 16 May 2022 | Sale | 34 | 253.87 | 8,632 | D |
18 May 2022 16:18 | VRTX | VERTEX PHARMACEUTICALS INC | LIU JOY | SVP, General Counsel | 16 May 2022 | Sale | 20 | 252.49 | 5,050 | D |
18 May 2022 16:18 | VRTX | VERTEX PHARMACEUTICALS INC | LIU JOY | SVP, General Counsel | 16 May 2022 | Sale | 19 | 251.57 | 4,780 | D |
18 May 2022 16:18 | VRTX | VERTEX PHARMACEUTICALS INC | LIU JOY | SVP, General Counsel | 16 May 2022 | Sale | 25 | 250.77 | 6,269 | D |
28 Jun 2022 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | KEWALRAMANI RESHMA | CEO & President | 24 Jun 2022 | Sale | 11,689 | 291.3 | 3,405,006 | D |
21 Jul 2022 16:48 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 19 Jul 2022 | Sale | 6,604 | 289.48 | 1,911,726 | D |
21 Jul 2022 16:48 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 19 Jul 2022 | Sale | 5,737 | 288.67 | 1,656,100 | D |
21 Jul 2022 16:48 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 19 Jul 2022 | Sale | 4,561 | 287.83 | 1,312,793 | D |
21 Jul 2022 16:48 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 19 Jul 2022 | Sale | 963 | 286.72 | 276,111 | D |
27 Jul 2022 16:17 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 25 Jul 2022 | Sale | 10,471 | 283.42 | 2,967,691 | D |
27 Jul 2022 16:17 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 25 Jul 2022 | Sale | 40,666 | 282.43 | 11,485,298 | D |
27 Jul 2022 16:17 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 25 Jul 2022 | Sale | 34,090 | 281.27 | 9,588,494 | D |
27 Jul 2022 16:17 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 25 Jul 2022 | Sale | 32,983 | 280.37 | 9,247,444 | D |
27 Jul 2022 16:17 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 25 Jul 2022 | Sale | 13,869 | 279.44 | 3,875,553 | D |
02 Aug 2022 16:16 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 29 Jul 2022 | Sale | 5 | 282.34 | 1,412 | D |
02 Aug 2022 16:16 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 29 Jul 2022 | Sale | 58 | 281.03 | 16,300 | D |
02 Aug 2022 16:16 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 29 Jul 2022 | Sale | 99 | 280.22 | 27,742 | D |
02 Aug 2022 16:16 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 29 Jul 2022 | Sale | 160 | 279.28 | 44,685 | D |
02 Aug 2022 16:16 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 29 Jul 2022 | Sale | 200 | 277.95 | 55,590 | D |
02 Aug 2022 16:16 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 29 Jul 2022 | Sale | 99 | 276.65 | 27,388 | D |
10 Aug 2022 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 08 Aug 2022 | Sale | 146 | 295.14 | 43,090 | D |
10 Aug 2022 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 08 Aug 2022 | Sale | 302 | 293.99 | 88,785 | D |
10 Aug 2022 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 08 Aug 2022 | Sale | 210 | 293.02 | 61,534 | D |
10 Aug 2022 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 08 Aug 2022 | Sale | 424 | 291.53 | 123,609 | D |
10 Aug 2022 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 08 Aug 2022 | Sale | 222 | 290.32 | 64,451 | D |
10 Aug 2022 16:07 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 08 Aug 2022 | Sale | 47 | 295.53 | 13,890 | D |
10 Aug 2022 16:07 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 08 Aug 2022 | Sale | 161 | 294.24 | 47,373 | D |
10 Aug 2022 16:07 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 08 Aug 2022 | Sale | 204 | 293.15 | 59,803 | D |
10 Aug 2022 16:07 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 08 Aug 2022 | Sale | 164 | 291.76 | 47,849 | D |
10 Aug 2022 16:07 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 08 Aug 2022 | Sale | 45 | 290.18 | 13,058 | D |
10 Aug 2022 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 09 Aug 2022 | Sale | 900 | 301.42 | 271,278 | D |
10 Aug 2022 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 09 Aug 2022 | Sale | 4,790 | 300.53 | 1,439,539 | D |
10 Aug 2022 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 09 Aug 2022 | Sale | 74 | 301.67 | 22,324 | D |
10 Aug 2022 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 09 Aug 2022 | Sale | 72 | 300.64 | 21,646 | D |
10 Aug 2022 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 09 Aug 2022 | Sale | 283 | 299.79 | 84,841 | D |
10 Aug 2022 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 09 Aug 2022 | Sale | 679 | 298.77 | 202,865 | D |
10 Aug 2022 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 09 Aug 2022 | Sale | 292 | 297.54 | 86,882 | D |
10 Aug 2022 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | LIU JOY | SVP, General Counsel | 09 Aug 2022 | Sale | 946 | 300 | 283,800 | D |
12 Aug 2022 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | LIU JOY | SVP, General Counsel | 10 Aug 2022 | Sale | 36 | 300.32 | 10,812 | D |
12 Aug 2022 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 10 Aug 2022 | Sale | 9 | 302.01 | 2,718 | D |
12 Aug 2022 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 10 Aug 2022 | Sale | 171 | 300.32 | 51,355 | D |
17 Aug 2022 17:39 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 15 Aug 2022 | Sale | 6,948 | 305.38 | 2,121,780 | D |
17 Aug 2022 17:39 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 15 Aug 2022 | Sale | 6,990 | 304.67 | 2,129,643 | D |
17 Aug 2022 17:39 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 15 Aug 2022 | Sale | 2,339 | 303.78 | 710,541 | D |
17 Aug 2022 17:39 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 15 Aug 2022 | Sale | 400 | 302.55 | 121,020 | D |
17 Aug 2022 17:39 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 15 Aug 2022 | Sale | 4,242 | 301.61 | 1,279,430 | D |
17 Aug 2022 17:39 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 15 Aug 2022 | Sale | 1,254 | 300.3 | 376,576 | D |
17 Aug 2022 17:40 | VRTX | VERTEX PHARMACEUTICALS INC | KEWALRAMANI RESHMA | CEO & President | 15 Aug 2022 | Sale | 11,689 | 305.06 | 3,565,846 | D |
17 Aug 2022 17:36 | VRTX | VERTEX PHARMACEUTICALS INC | LIU JOY | SVP, General Counsel | 15 Aug 2022 | Sale | 300 | 305.57 | 91,671 | D |
17 Aug 2022 17:36 | VRTX | VERTEX PHARMACEUTICALS INC | LIU JOY | SVP, General Counsel | 15 Aug 2022 | Sale | 1,743 | 305.01 | 531,632 | D |
17 Aug 2022 17:36 | VRTX | VERTEX PHARMACEUTICALS INC | LIU JOY | SVP, General Counsel | 15 Aug 2022 | Sale | 700 | 303.99 | 212,793 | D |
17 Aug 2022 17:36 | VRTX | VERTEX PHARMACEUTICALS INC | LIU JOY | SVP, General Counsel | 15 Aug 2022 | Sale | 100 | 302.35 | 30,235 | D |
17 Aug 2022 17:36 | VRTX | VERTEX PHARMACEUTICALS INC | LIU JOY | SVP, General Counsel | 15 Aug 2022 | Sale | 698 | 301.63 | 210,538 | D |
17 Aug 2022 17:36 | VRTX | VERTEX PHARMACEUTICALS INC | LIU JOY | SVP, General Counsel | 15 Aug 2022 | Sale | 206 | 300.26 | 61,854 | D |
20 Oct 2022 16:11 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 18 Oct 2022 | Sale | 288 | 301.84 | 86,930 | D |
20 Oct 2022 16:11 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 18 Oct 2022 | Sale | 1,503 | 300.02 | 450,930 | D |
26 Oct 2022 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 24 Oct 2022 | Sale | 621 | 310 | 192,510 | D |
03 Nov 2022 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 02 Nov 2022 | Sale | 22 | 317.77 | 6,991 | D |
03 Nov 2022 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 02 Nov 2022 | Sale | 10 | 315.68 | 3,157 | D |
03 Nov 2022 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 02 Nov 2022 | Sale | 12 | 314.43 | 3,773 | D |
03 Nov 2022 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 02 Nov 2022 | Sale | 81 | 313.37 | 25,383 | D |
03 Nov 2022 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 02 Nov 2022 | Sale | 100 | 312.4 | 31,240 | D |
03 Nov 2022 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 02 Nov 2022 | Sale | 39 | 311.17 | 12,136 | D |
03 Nov 2022 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 02 Nov 2022 | Sale | 56 | 310.1 | 17,366 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)